GB9920558D0 - Methods for particle formation and their products - Google Patents
Methods for particle formation and their productsInfo
- Publication number
- GB9920558D0 GB9920558D0 GBGB9920558.5A GB9920558A GB9920558D0 GB 9920558 D0 GB9920558 D0 GB 9920558D0 GB 9920558 A GB9920558 A GB 9920558A GB 9920558 D0 GB9920558 D0 GB 9920558D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- products
- methods
- particle formation
- particle
- formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0407—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solute
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
- B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0488—Flow sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9920558.5A GB9920558D0 (en) | 1999-08-31 | 1999-08-31 | Methods for particle formation and their products |
AU68550/00A AU783570B2 (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
EP00956682A EP1207856A2 (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
KR1020027002715A KR20020047137A (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
GB0220996A GB2381453A (en) | 1999-08-31 | 2000-08-31 | Active/polymer coformulations |
CA002382556A CA2382556A1 (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
GB0021227A GB2355194B (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
JP2001519878A JP2003508419A (en) | 1999-08-31 | 2000-08-31 | Co-compounding methods and their products |
PCT/GB2000/003328 WO2001015664A2 (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
MXPA02001803A MXPA02001803A (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9920558.5A GB9920558D0 (en) | 1999-08-31 | 1999-08-31 | Methods for particle formation and their products |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9920558D0 true GB9920558D0 (en) | 1999-11-03 |
Family
ID=10860085
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9920558.5A Ceased GB9920558D0 (en) | 1999-08-31 | 1999-08-31 | Methods for particle formation and their products |
GB0021227A Expired - Fee Related GB2355194B (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0021227A Expired - Fee Related GB2355194B (en) | 1999-08-31 | 2000-08-31 | Coformulation methods and their products |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1207856A2 (en) |
JP (1) | JP2003508419A (en) |
KR (1) | KR20020047137A (en) |
AU (1) | AU783570B2 (en) |
CA (1) | CA2382556A1 (en) |
GB (2) | GB9920558D0 (en) |
MX (1) | MXPA02001803A (en) |
WO (1) | WO2001015664A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60038162T2 (en) | 1999-12-08 | 2009-02-26 | Pharmacia Corp. | CELECOXIB IN SOLID BODY FORM WITH INCREASED BIOAVAILABILITY |
CH694686A5 (en) | 2000-03-04 | 2005-06-15 | Eco2 Sa | Product micronization of pharmaceutical substances. |
FR2815540B1 (en) † | 2000-10-19 | 2005-06-10 | Separex Sa | PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE |
GB0027357D0 (en) * | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
GB0102075D0 (en) | 2001-01-26 | 2001-03-14 | Astrazeneca Ab | Process |
DE60226140T2 (en) * | 2001-05-30 | 2009-05-07 | Csir, Pretoria | METHOD FOR THE SECULATION OF AN ACTIVE SUBSTANCE |
US20050260273A1 (en) * | 2001-06-07 | 2005-11-24 | Chinea Vanessa I | Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology |
US20050271737A1 (en) * | 2001-06-07 | 2005-12-08 | Chinea Vanessa I | Application of a bioactive agent to a substrate |
US7767249B2 (en) * | 2001-06-07 | 2010-08-03 | Hewlett-Packard Development Company, L.P. | Preparation of nanoparticles |
MXPA03011784A (en) | 2001-06-22 | 2004-04-02 | Pfizer Prod Inc | Pharmaceutical compositions of dispersions of drugs and neutral polymers. |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
MXPA04003718A (en) | 2001-10-22 | 2004-07-30 | Dompe Spa | Supercritical fluids processing: preparation of protein microparticles and their stabilisation. |
DE60227691D1 (en) | 2001-11-01 | 2008-08-28 | Nektar Therapeutics | SPRAY DRYING PROCESS |
DE60320940D1 (en) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF ACTIVE SUBSTANCES AND LIPOPHILIC MICROPHASE-BASED MATERIALS |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
KR20060015587A (en) | 2003-05-08 | 2006-02-17 | 넥타 쎄라퓨틱스 유케이 리미티드 | Particulate materials |
BRPI0413277A (en) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | pharmaceutical compositions of amorphous drug adsorbates and lipophilic microphase forming materials |
US7507823B2 (en) | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
US7744923B2 (en) | 2006-10-11 | 2010-06-29 | Crititech, Inc. | Method for precipitation of small medicament particles into use containers |
GB0702402D0 (en) | 2007-02-08 | 2007-03-21 | Thar Pharmaceuticals Inc | Method of creating crystalline substances |
EP2120875B1 (en) | 2007-02-11 | 2018-07-11 | Map Pharmaceuticals Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
EP2229233B1 (en) | 2007-12-07 | 2019-10-09 | XSpray Pharma AB (publ) | Method for the production of particles |
GB0812742D0 (en) | 2008-07-11 | 2008-08-20 | Critical Pharmaceuticals Ltd | Process |
MX350838B (en) | 2011-02-11 | 2017-09-18 | Grain Proc Corporation * | Salt composition. |
MX371209B (en) * | 2012-01-13 | 2020-01-22 | Xspray Microparticles Ab | A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component. |
CN104159577B (en) * | 2012-01-13 | 2017-03-15 | X喷雾微粒公司 | The pharmaceutical composition of stable, the amorphous hybrid nanomaterial of component is formed comprising at least one kinases inhibitor and at least one polymer stabilizing with substrate |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
EP0462066A1 (en) * | 1990-06-15 | 1991-12-18 | Warner-Lambert Company | Amorphous gemfibrozil |
DE4041563A1 (en) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | METHOD FOR PRODUCING ACTIVE MICROPARTICLES FROM HYDROLYTICALLY DEGRADABLE POLYMERS |
IT1255792B (en) * | 1992-08-05 | 1995-11-16 | Bayer Italia Spa | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINS IN THE FORM OF DRINK |
GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
IE75744B1 (en) * | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
SI9500173B (en) * | 1995-05-19 | 2002-02-28 | Lek, | Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |
TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
WO1997031691A1 (en) * | 1996-03-01 | 1997-09-04 | The University Of Kansas | Methods and apparatus for particle precipitation and coating using near-critical and supercritical antisolvents |
TR199802345T2 (en) * | 1996-05-17 | 1999-03-22 | Merck & Co., Inc. | Compositions for once-daily administration in cyclooxygenase-2-mediated diseases. |
FR2753639B1 (en) * | 1996-09-25 | 1998-12-11 | PROCESS FOR THE PREPARATION OF MICROCAPSULES OF ACTIVE MATERIALS COATED WITH A POLYMER AND NOVEL MICROCAPSULES OBTAINED IN PARTICULAR BY THE PROCESS | |
US5980942A (en) * | 1997-01-23 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release matrix tablet formulations of carbamazepine |
IT1296464B1 (en) * | 1997-11-19 | 1999-06-25 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DRUG-LOADED CROSS-LINKED POLYMER POWDERS AND RELATED PREPARATION PROCESS BY MEANS |
DE19821951A1 (en) * | 1998-05-15 | 1999-11-18 | Basf Ag | Orally administered solid or liquid cyclosporin compositions |
US6465011B2 (en) * | 1999-05-29 | 2002-10-15 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
GB9915975D0 (en) * | 1999-07-07 | 1999-09-08 | Bradford Particle Design Ltd | Method for the formation of particles |
-
1999
- 1999-08-31 GB GBGB9920558.5A patent/GB9920558D0/en not_active Ceased
-
2000
- 2000-08-31 EP EP00956682A patent/EP1207856A2/en not_active Withdrawn
- 2000-08-31 JP JP2001519878A patent/JP2003508419A/en active Pending
- 2000-08-31 GB GB0021227A patent/GB2355194B/en not_active Expired - Fee Related
- 2000-08-31 KR KR1020027002715A patent/KR20020047137A/en not_active Application Discontinuation
- 2000-08-31 CA CA002382556A patent/CA2382556A1/en not_active Abandoned
- 2000-08-31 MX MXPA02001803A patent/MXPA02001803A/en active IP Right Grant
- 2000-08-31 AU AU68550/00A patent/AU783570B2/en not_active Ceased
- 2000-08-31 WO PCT/GB2000/003328 patent/WO2001015664A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001015664A2 (en) | 2001-03-08 |
AU783570B2 (en) | 2005-11-10 |
GB0021227D0 (en) | 2000-10-18 |
WO2001015664A3 (en) | 2001-09-20 |
AU6855000A (en) | 2001-03-26 |
KR20020047137A (en) | 2002-06-21 |
GB2355194B (en) | 2003-01-08 |
GB2355194A (en) | 2001-04-18 |
JP2003508419A (en) | 2003-03-04 |
MXPA02001803A (en) | 2004-02-26 |
CA2382556A1 (en) | 2001-03-08 |
EP1207856A2 (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9920558D0 (en) | Methods for particle formation and their products | |
GB2354765B (en) | Dispersion composition and method for producing the same | |
AU2373200A (en) | Apparatuses and methods for forming assemblies | |
EP1230016A4 (en) | Particle production apparatus | |
IL148073A0 (en) | Apparatus and methods for the production of powders | |
HUP0104914A3 (en) | Galenicformulations fast disintegrating the mouth and method for preparing same | |
EP1198184A4 (en) | Appliqu method and article | |
AU1957201A (en) | Methods and systems for selecting travel products | |
HK1047125A1 (en) | Systems and methods for producing and using fine particle materials | |
IL146808A0 (en) | Methods for coating particles and particles produced thereby | |
AU6027300A (en) | Methods and means for producing improved dairy products | |
GB9928490D0 (en) | Products and processes therefor | |
AU2001274740A1 (en) | High density products and method for the preparation thereof | |
AU1064800A (en) | Products and methods | |
HK1048889A1 (en) | Component and method for the production thereof | |
HUP0105166A3 (en) | Substances wk-5344a and wk-5344b and process for producing the same | |
GB0017586D0 (en) | Method and means for particle measurement | |
AU6449500A (en) | Method for obtaining health-promoting products and resulting products | |
EP1172442A4 (en) | Vitamin d derivatives and process for producing the same | |
AU7738600A (en) | Reduced gravity transformation process and product | |
AU5751200A (en) | Detergent particles and methods for making them | |
AU7023300A (en) | Product and method | |
GB9912059D0 (en) | Products and methods | |
GB9914202D0 (en) | Products and methods | |
GB9917273D0 (en) | Products and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |